Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
14.2 Monotherapy Use of MOUNJARO in Adult Patients with Type 2 Diabetes Mellitus SURPASS-1 (NCT03954834) was a 40-week double-blind trial that randomized 478 adult patients with type 2 diabetes mellitus with inadequate glycemic control with diet and exercise to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg, or placebo once weekly
Food and Drug Administration (FDA) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
It is about time we managed the deficiencies with the right health choices such as food, supplements and B12 injection at home in Noida
Adjustments may be made based on the individual response and any emerging complications
US$ 22.37
US$ 20.74
US$ 22.36
